Shanda Hofmann
Nurse Practitioner · Charleston, SCNPI 1811660822
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 414 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,457 and has fallen 93.7% since, to $218 in 2025. Among nurse practitioner clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 414 payments — averaging $25.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$2K
- AstraZeneca$1K
- Pfizer$848
- Amgen$819
- Esperion Therapeutics, Inc.$709
- Merck$597
- plus $5K from 33 others
What the payments were for
- Consulting fees$170%
- Food & beverage$10,707100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 58 | $1,858 |
| AstraZeneca | 35 | $1,013 |
| Pfizer | 39 | $848 |
| Amgen | 36 | $819 |
| Esperion Therapeutics, Inc. | 18 | $709 |
| Merck | 26 | $597 |
| Lilly USA, LLC | 17 | $501 |
| AbbVie | 17 | $480 |
| Johnson & Johnson | 23 | $473 |
| Bayer | 20 | $448 |
| E.r. Squibb & Sons, L.L.C. | 20 | $446 |
| Novo Nordisk | 18 | $421 |
| Amarin Pharma, Inc. | 16 | $294 |
| GSK | 8 | $292 |
| Novartis | 7 | $220 |
| Redhill Biopharma Inc. | 7 | $173 |
| Exact Sciences | 6 | $132 |
| Sanofi-aventis U.S. LLC | 2 | $126 |
| Heartflow, Inc. | 2 | $88 |
| Scpharmaceuticals Inc. | 5 | $80 |
| Irhythm Technologies, Inc. | 1 | $75 |
| Inspire Medical Systems, Inc. | 2 | $62 |
| Cvrx, Inc. | 5 | $62 |
| Scilex Pharmaceuticals Inc. | 3 | $55 |
| Atricure, Inc. | 1 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $52 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $51 |
| Impulse Dynamics (USA) Inc. | 3 | $49 |
| Medtronic | 1 | $41 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $34 |
| Lexicon Pharmaceuticals, Inc. | 1 | $30 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $27 |
| Viiv Healthcare Company | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Baxter Healthcare | 1 | $17 |
| Phadia US Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,738 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 240 | $283,247 |
| JardianceEmpagliflozin | 170 | $226,022 |
| EntrestoSacubitril/Valsartan | 96 | $127,734 |
| XareltoRivaroxaban | 88 | $117,052 |
| VascepaIcosapent Ethyl | 53 | $36,515 |
| NexlizetBempedoic Acid/Ezetimibe | 39 | $34,735 |
| Repatha SureclickEvolocumab | 37 | $29,442 |
| VerquvoVericiguat | 19 | $22,210 |
| BrilintaTicagrelor | 21 | $21,990 |
| FarxigaDapagliflozin Propanediol | 14 | $17,053 |
| NexletolBempedoic Acid | 13 | $14,621 |
| Repatha PushtronexEvolocumab | 21 | $12,590 |
| Metoprolol Succinate | 443 | $5,525 |
| Rosuvastatin Calcium | 428 | $4,987 |
| Atorvastatin Calcium | 603 | $4,914 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $848 | $283,247240 claims |
| Boehringer IngelheimJardiance | $1,858 | $226,022170 claims |
| NovartisEntresto | $220 | $127,73496 claims |
| Johnson & JohnsonXarelto | $473 | $117,05288 claims |
| Esperion Therapeutics, Inc.Nexlizet, Nexletol | $709 | $49,35652 claims |
| AstraZenecaBrilinta, Farxiga | $1,013 | $39,04335 claims |
| MerckVerquvo | $597 | $22,21019 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Charleston
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kellie McLainCharleston$28K
- Kristen LaudatiCharleston$15K
- Alice MazzellaCharleston$12K
- Samantha PecunesCharleston$12K
- Christine BrusmanCharleston$12K
- Diane BurdsalCharleston$10K
- Kendall BowlerCharleston$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.